Skip to content
rticc logo
Bruce and Ruth Rappaport Cancer Research Center
  • About
  • Research
  • Members
  • News
  • Join
  • Contact

SUPPORT US
technion logo
D. Dan and Betty Kahn Human Health Building
SUPPORT US
technion logo
D. Dan and Betty Kahn Human Health Building
×
  • About Us
    • Mission and Vision
      • Our History
      • From the Director
    • Leadership & Management
    • Support Us
      • RTICC Supporters
      • Make Your Impact
    • Rappaport-Technion Research Program
    • D. Dan & Betty Kahn Human Health Building
  • Research
    • Cancer Biology
      • The Cancer Cell
      • Cancer Stem Cell
      • Epigenetics & Genomics
      • Metabolism
      • ECM
      • Tumor Microenvironment
      • Cancer Immunology
      • Systems Biology
    • Exact Sciences & Engineering
      • Cancer Chemistry
      • Cancer Biophysics
      • Drug Design
      • Drug Delivery
      • Nanotechnology
      • Imaging
      • Devices
    • Computation & AI
      • Computational Cancer Biology
      • Big Data Analysis
      • Machine Learning
      • AI
    • Translational / Clinical Research
      • Cancer Prevention & Diagnosis
      • Biomarkers
      • Drug Discovery
      • Early Clinical Trials
      • Personalized Medicine
      • Targeted Therapy
    • Core Facilities
      • Biomedical Core Facility
      • ATGC Genomics Center
      • Pre-Clinical Research Authority
      • Perlmutter Metabolomics Center
      • Smoler Protein Research Center
      • LS&E
      • The Russell Berrie NNSCC
    • Funding Opportunities
      • RTICC Fellows
    • Research Initiatives
    • Innovation& Inventions
    • RTICC Resources
  • Members
    • RTICC Members
      • Researchers by Topics
      • A-Z Researchers
      • Faculties & Hospitals
    • Partners & Collaborations
    • External Affiliated Researchers
  • News & Events
    • News
    • Seminars & Events
    • Newsletters
  • Join
    • Careers for Faculty Members
    • Scientific Staff Vacancies
    • Post-Doc & Graduate Students Info
  • Contact Us
  • Support Us

About

  • Mission and Vision
    • Our History
    • From the Director
  • Leadership & Management
  • Support Us
    • RTICC Supporters
    • Make Your Impact
  • Rappaport-Technion Research Program
  • D. Dan & Betty Kahn Human Health Building
  • Mission and Vision
    • Our History
    • From the Director
  • Leadership & Management
  • Support Us
    • RTICC Supporters
    • Make Your Impact
  • Rappaport-Technion Research Program
  • D. Dan & Betty Kahn Human Health Building

Research

  • Cancer Biology
    • Cancer Immunology
    • ECM
    • Metabolism
    • Systems Biology
    • Tumor Microenvironment
    • The Cancer Cell
    • Cancer Stem Cell
    • Epigenetics & Genomics
  • Exact Sciences & Engineering
    • Cancer Biophysics
    • Cancer Chemistry
    • Devices
    • Drug Delivery
    • Drug Design
    • Imaging
    • Nanotechnology
  • Computation & AI
    • AI
    • Big Data Analysis
    • Computational Cancer Biology
    • Machine Learning
  • Translational / Clinical Research
    • Cancer Prevention & Diagnosis
    • Biomarkers
    • Drug Discovery
    • Early Clinical Trials
    • Personalized Medicine
    • Targeted Therapy
  • Core Facilities
    • Biomedical Core Facility
    • ATGC Genomics Center
    • Pre-Clinical Research Authority
    • Perlmutter Metabolomics Center
    • Smoler Protein Research Center
    • LS&E
    • The Russell Berrie NNSCC
  • Funding Opportunities
    • RTICC Fellows
  • Research Initiatives
  • Innovation& Inventions
  • RTICC Cell Lines Database
  • Cancer Biology
    • Cancer Immunology
    • ECM
    • Metabolism
    • Systems Biology
    • Tumor Microenvironment
    • The Cancer Cell
    • Cancer Stem Cell
    • Epigenetics & Genomics
  • Exact Sciences & Engineering
    • Cancer Biophysics
    • Cancer Chemistry
    • Devices
    • Drug Delivery
    • Drug Design
    • Imaging
    • Nanotechnology
  • Computation & AI
    • AI
    • Big Data Analysis
    • Computational Cancer Biology
    • Machine Learning
  • Translational / Clinical Research
    • Cancer Prevention & Diagnosis
    • Biomarkers
    • Drug Discovery
    • Early Clinical Trials
    • Personalized Medicine
    • Targeted Therapy
  • Core Facilities
    • Biomedical Core Facility
    • ATGC Genomics Center
    • Pre-Clinical Research Authority
    • Perlmutter Metabolomics Center
    • Smoler Protein Research Center
    • LS&E
    • The Russell Berrie NNSCC
  • Funding Opportunities
    • RTICC Fellows
  • Research Initiatives
  • Innovation& Inventions
  • RTICC Cell Lines Database

Members

  • RTICC Members
    • Faculty Researchers by Topics
    • A-Z Researchers
    • Faculties & Hospitals
  • Partners & Collaborations
  • External Affiliated Researchers
  • RTICC Members
    • Faculty Researchers by Topics
    • A-Z Researchers
    • Faculties & Hospitals
  • Partners & Collaborations
  • External Affiliated Researchers

News

  • News
    • Newsletters
  • Seminars and Events
  • News
    • Newsletters
  • Seminars and Events

Join

  • Careers for Faculty Members
  • Scientific Staff Vacancies
  • Post-Doc & Graduate Students Info
  • Careers for Faculty Members
  • Scientific Staff Vacancies
  • Post-Doc & Graduate Students Info

FACULTY

Researchers

Dina Ron, PhD, Professor

Prof. Dina Ron, Faculty of Biology

We study mechanisms that inhibit tumor initiation and progression, the link between inflammation and cancer, and exploiting the knowledge gained for cancer therapy.

Tags:

Cancer Prevention and Diagnosis
Epigenetics & Genomics
The Cancer Cell
Tumor Microenvironment
Tumor Suppressor Genes
Faculty of Biology
+972-73-3784217
dinar@technion.ac.il
Lab Website
JOIN
over 80 RTICC faculty members
Subscribe
to Our Newsletter
RTICC - Bruce and Ruth Rappaport Cancer Research Center
technion logo
D. Dan and Betty Kahn Human Health Building white logo

© 2025 RTiCC
Bruce and Ruth Rappaport Cancer Research Center
Accessibility Statement

Scroll To Top